nan
Bottle Drying Rack Counter Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The peyronies disease treatment market has experienced rapid expansion in its size over recent years. This market is projected to expand from $1.05 billion in 2025 to $1.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this growth can be attributed to several factors, including the increasing incidence of Peyronie’s disease and related erectile dysfunction cases, heightened public awareness concerning male sexual health issues, the scarcity of early-stage non-surgical therapeutic choices, a rise in the use of surgical correction methods for advanced conditions, and the development of specialized urology care facilities.
The peyronies disease treatment market is anticipated to experience rapid growth in the coming years, with its size projected to reach $1.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is fueled by factors such as the increasing development of novel antifibrotic drug therapies and biologics, a rising demand for non-invasive and outpatient treatment options, expanding clinical research into regenerative medicine approaches for penile tissue repair, a growing patient preference for combination therapy protocols, and broadening healthcare access and reimbursement support for men’s health treatments. Prominent trends for the forecast period include the expansion of oral pharmacological therapy, increasing adoption of collagenase injection-based treatments for plaque reduction, a rising preference for penile traction device therapy in curvature correction, growing utilization of low-intensity shockwave therapy for pain and fibrosis management, and an expanding shift toward minimally invasive surgical correction and combination therapy approaches.
Download A Free Sample Report For Comprehensive Market Insights:
Peyronies Disease Treatment Market Industry Drivers: What Is Driving Revenue Growth?
The increasing emphasis on men’s health is projected to drive the expansion of the peyronies disease treatment market in the foreseeable future. Men’s health pertains to the physical, mental, and reproductive well-being of males, including the prevention, diagnosis, and treatment of conditions that predominantly or exclusively affect them. This heightened focus on men’s health is growing due to greater recognition of male-specific ailments, as both the public and healthcare systems are increasingly identifying conditions unique to men, leading to earlier detection, improved education, and enhanced access to specialized medical care. An increased focus on men’s health positively influences peyronie’s disease treatment by encouraging broader awareness, earlier diagnoses, and a greater willingness among men to seek medical consultation for urological problems, which ultimately results in higher adoption of specialized therapies and improved treatment outcomes. For instance, in July 2025, figures from the Local Government Association, a UK-based organization, indicated that over 2.74 million individuals accessed sexual health clinics in England in 2023, with men constituting more than 60% of all new sexually transmitted infection (STI) diagnoses across the country. Therefore, the growing emphasis on men’s health is a key factor propelling the growth of the peyronies disease treatment market.
Bottle Drying Rack Counter Market Segmentation Trends And Revenue Drivers
The peyronies disease treatment market covered in this report is segmented –
1) By Treatment Type: Non Surgical Treatments; Surgical Treatments
2) By Route Of Administration: Oral; Injectable; Topical; Device Based Or External
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Non Surgical Treatments: Oral Drug Therapy Treatments; Intralesional Injection Therapy Treatments; Shockwave Therapy Treatments; Traction Device Therapy Treatments
2) By Surgical Treatments: Plication Surgery Treatments; Grafting Surgery Treatments; Penile Prosthesis Implant Surgery Treatments; Plaque Incision And Excision Surgery Treatments
Innovation In Spatial Computing Advances Precision Training For Minimally Invasive Injectable Therapies
Major companies operating in the peyronies disease treatment market are focusing on developing innovative solutions, such as mixed reality injection training platforms, to enhance physician training, improve injection accuracy, and support safer and more effective treatment outcomes. Mixed reality injection training platforms are immersive medical training systems that combine virtual 3D anatomy with real-world interaction to simulate injection procedures, helping clinicians practice techniques in a risk-free environment to improve accuracy, confidence, and patient safety during actual treatments. For instance, in April 2025, Endo Pharmaceuticals, a US-based pharmaceutical company, launched Endo’s Spatial Computing Injection Simulator for Peyronie’s disease, an innovative training solution. The product integrates immersive spatial computing environments, anatomically accurate 3D modeling, and guided procedural workflows to simulate intralesional injection techniques used in clinical management of Peyronie’s disease. It enables healthcare professionals to rehearse patient-specific injection scenarios, improves understanding of plaque localization and curvature correction strategies, and reduces variability in real-world procedures through repetitive, risk-free practice. The simulator also supports standardized medical training across institutions, helping expand access to advanced Peyronie’s disease therapies by improving clinician proficiency and procedural consistency.
Peyronies Disease Treatment Market Leading Companies Driving Competitive Growth
Major companies operating in the peyronies disease treatment market are Keenova Therapeutics plc; Coloplast A/S; Boston Scientific Corporation; Viatris Inc.
Access The Complete Peyronies Disease Treatment Market Report:
Peyronies Disease Treatment Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the peyronies disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peyronies disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.